keyword
https://read.qxmd.com/read/38574738/an-integrated-multi-omics-analysis-reveals-osteokines-involved-in-global-regulation
#21
JOURNAL ARTICLE
Wenquan Liang, Tiantian Wei, Le Hu, Meijun Chen, Liping Tong, Wu Zhou, Xingwei Duan, Xiaoyang Zhao, Weijie Zhou, Qing Jiang, Guozhi Xiao, Weiguo Zou, Di Chen, Zhipeng Zou, Xiaochun Bai
Bone secretory proteins, termed osteokines, regulate bone metabolism and whole-body homeostasis. However, fundamental questions as to what the bona fide osteokines and their cellular sources are and how they are regulated remain unclear. In this study, we analyzed bone and extraskeletal tissues, osteoblast (OB) conditioned media, bone marrow supernatant (BMS), and serum, for basal osteokines and those responsive to aging and mechanical loading/unloading. We identified 375 candidate osteokines and their changes in response to aging and mechanical dynamics by integrating data from RNA-seq, scRNA-seq, and proteomic approaches...
March 28, 2024: Cell Metabolism
https://read.qxmd.com/read/38571645/development-of-dual-polarization-battery-model-with-high-accuracy-for-a-lithium-ion-battery-cell-under-dynamic-driving-cycle-conditions
#22
JOURNAL ARTICLE
Merve Tekin, M Ihsan Karamangil
Lithium-ion batteries are a key technology for electric vehicles. They are suitable for use in electric vehicles as they provide long range and long life. However, Lithium-ion batteries need to be controlled by a Battery Management System (BMS) to operate safely and efficiently. The BMS continuously controls parameters, such as current, voltage, temperature, state of charge (SoC), and state of health (SoH), and protects the battery against overcharging and discharging, imbalances between cells, and thermal runaways...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38569071/saliva-and-tongue-microbiota-in-burning-mouth-syndrome-an-exploratory-study-of-potential-roles
#23
JOURNAL ARTICLE
Shuangshuang Wu, Linman Li, Xu Wang, Zhimin Yan
OBJECTIVES: Burning mouth syndrome (BMS) is a chronic orofacial pain disorder with unclear etiology, in which the tongue is most commonly affected. This study aims to provide implication of the possible relationship between oral microbiota and the pathogenesis of BMS. MATERIALS AND METHODS: Saliva and tongue swabs of 15 primary BMS patients and 10 healthy controls were collected and assessed by 16S rRNA gene amplicon sequencing. The microbiota compositions were compared and bioinformatic analysis was conducted...
April 3, 2024: Oral Diseases
https://read.qxmd.com/read/38567144/cost-of-treatment-for-brain-metastases-using-data-from-a-national-health-insurance
#24
JOURNAL ARTICLE
Joseph Crooks, Oralia Dominic, Matthew Shepard, Alexander Yu, Yun Liang, Stephen M Karlovits, Rodney E Wegner
PURPOSE: In the United States, brain metastases (BMs) affect 10% to 20% of patients with cancer, presenting a significant health care challenge and necessitating intricate, high-cost treatments. Few studies have explored the comprehensive care cost for BMs, and none have used real insurance claims data. Partnering with a northeastern health care insurer, we investigated the true costs of various brain-directed radiation methods, aiming to shed light on treatment expenses, modalities, and their efficacy...
May 2024: Advances in Radiation Oncology
https://read.qxmd.com/read/38563856/comparative-analysis-of-the-spatial-distribution-of-brain-metastases-across-several-primary-cancers-using-machine-learning-and-deep-learning-models
#25
JOURNAL ARTICLE
Saeedeh Mahmoodifar, Dhiraj J Pangal, Josh Neman, Gabriel Zada, Jeremy Mason, Bodour Salhia, Tehila Kaisman-Elbaz, Selcuk Peker, Yavuz Samanci, Andréanne Hamel, David Mathieu, Manjul Tripathi, Jason Sheehan, Stylianos Pikis, Georgios Mantziaris, Paul K Newton
OBJECTIVE: Brain metastases (BM) are associated with poor prognosis and increased mortality rates, making them a significant clinical challenge. Studying BMs can aid in improving early detection and monitoring. Systematic comparisons of anatomical distributions of BM from different primary cancers, however, remain largely unavailable. METHODS: To test the hypothesis that anatomical BM distributions differ based on primary cancer type, we analyze the spatial coordinates of BMs for five different primary cancer types along principal component (PC) axes...
April 2, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38558265/change-in-taste-sensation-after-orthognathic-surgery
#26
JOURNAL ARTICLE
Yagmur Malkoc, Serap Gulsever, Sina Uckan
OBJECTIVE: The objective of this study was to evaluate the effect of orthognathic surgery on taste sensation. MATERIALS AND METHODS: Thirty-five patients scheduled to undergo Le Fort I osteotomy (LFIO), sagittal split ramus osteotomy (SSRO), and bimaxillary surgery (BMS) were evaluated by administering localized and whole-mouth taste tests preoperatively and postoperatively at months 1, 3, and 6. The patients were asked to identify the quality of four basic tastes applied to six locations on the palate and tongue and to rate the taste intensities they perceived...
April 1, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38552183/discovery-of-2-3-dihydro-1-4-dioxino-2-3-g-benzofuran-derivatives-as-protease-activated-receptor-4-par4-antagonists-with-potent-antiplatelet-aggregation-activity-and-low-bleeding-tendency
#27
JOURNAL ARTICLE
Panpan Chen, Cai Chen, Yizheng Zheng, Fangjun Chen, Zhaojun Liu, Shenhong Ren, Hangyu Song, Tongdan Liu, Zhipeng Lu, Hongbin Sun, Yi Kong, Haoliang Yuan
Patients with arterial embolic disease have benefited greatly from antiplatelet therapy. However, hemorrhage risk of antiplatelet agents cannot be ignored. Herein, we describe the discovery of 2,3-dihydro[1,4]dioxino[2,3- g ]benzofuran compounds as novel PAR4 antagonists. Notably, the isomers 36 and 37 with the chemotype of phenoxyl methylene substituted on the 2,3-dihydro-1,4-dioxine ring exhibited potent in vitro antiplatelet activity (IC50 = 26.13 nM for 36 and 14.26 nM for 37 ) and significantly improved metabolic stability in human liver microsomes ( T 1/2 = 97...
March 29, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38551536/galectin-10-in-serum-extracellular-vesicles-reflects-asthma-pathophysiology
#28
JOURNAL ARTICLE
Hanako Yoshimura, Yoshito Takeda, Yuya Shirai, Makoto Yamamoto, Daisuke Nakatsubo, Saori Amiya, Takatoshi Enomoto, Reina Hara, Yuichi Adachi, Ryuya Edahiro, Moto Yaga, Kentaro Masuhiro, Taro Koba, Miho Itoh-Takahashi, Mana Nakayama, So Takata, Yuki Hosono, Sho Obata, Masayuki Nishide, Akinori Hata, Masahiro Yanagawa, Satoko Namba, Michio Iwata, Momoko Hamano, Haruhiko Hirata, Shohei Koyama, Kota Iwahori, Izumi Nagatomo, Yasuhiko Suga, Kotaro Miyake, Takayuki Shiroyama, Kiyoharu Fukushima, Shinji Futami, Yujiro Naito, Takahiro Kawasaki, Kenji Mizuguchi, Yusuke Kawashima, Yoshihiro Yamanishi, Jun Adachi, Mari Nogami-Itoh, Shigeharu Ueki, Atsushi Kumanogoh
BACKGROUND: Novel biomarkers (BMs) are urgently needed for bronchial asthma (BA) with various phenotypes and endotypes. OBJECTIVE: We sought to identify novel BMs reflecting tissue pathology from serum extracellular vesicles (EVs). METHODS: We performed data-independent acquisition of serum EVs from 4 healthy controls, 4 noneosinophilic asthma (NEA) patients, and 4 eosinophilic asthma (EA) patients to identify novel BMs for BA. We confirmed EA-specific BMs via data-independent acquisition validation in 61 BA patients and 23 controls...
March 14, 2024: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/38547523/the-protective-effects-of-ruscogenin-against-lipopolysaccharide-induced-myocardial-injury-in-septic-mice
#29
JOURNAL ARTICLE
Rui-Yu Wang, Ming-Gui Wang, Han-Zhang Tang, Hui Du, Yue Luo, Quan Li, Xiao-Hong Zhang, Jing Fu, Chuan-Zhu Lv
Sepsis-induced myocardial dysfunction (SIMD) commonly occurs in individuals with sepsis and is a severe complication with high morbidity and mortality rates. The current study aimed to investigate the effects and potential mechanisms of the natural steroidal sapogenin ruscogenin (RUS) against lipopolysaccharide (LPS)-induced myocardial injury in septic mice. We found that RUS effectively alleviated myocardial pathological damage, normalized cardiac function, and increased survival in septic mice. RNA sequencing (RNA-seq) demonstrated that RUS administration significantly inhibited the activation of the NOD-like receptor signaling pathway in the myocardial tissues of septic mice...
March 25, 2024: Journal of Cardiovascular Pharmacology
https://read.qxmd.com/read/38545432/intracranial-efficacy-of-pyrotinib-and-capecitabine-combination-therapy-in-her2-positive-breast-cancer-with-brain-metastases
#30
JOURNAL ARTICLE
Congcong Wang, Jinyu Xiang, Qingyu Zhang, Jing Li, Yanqing Liu, Jiannan Liu
AIM: Approximately 50% of patients diagnosed with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (BC) are estimated to develop brain metastases (BMs). This study was aimed to assess the intracranial efficacy and survival benefits of pyrotinib and capecitabine combination therapy in the treatment of BMs in patients with HER2-positive BC. METHODS: A total of 56 HER2-positive BC patients with BMs were treated with 400 mg pyrotinib once daily along with 1000 mg/m2 capecitabine twice daily for 14 days in 21-day cycles...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38543102/a-comprehensive-computational-insight-into-the-pd-l1-binding-to-pd-1-and-small-molecules
#31
REVIEW
Marialuigia Fantacuzzi, Roberto Paciotti, Mariangela Agamennone
Immunotherapy has marked a revolution in cancer therapy. The most extensively studied target in this field is represented by the protein-protein interaction between PD-1 and its ligand, PD-L1. The promising results obtained with the clinical use of monoclonal antibodies (mAbs) directed against both PD-1 and PD-L1 have prompted the search for small-molecule binders capable of disrupting the protein-protein contact and overcoming the limitations presented by mAbs. The disclosure of the first X-ray complexes of PD-L1 with BMS ligands showed the protein in dimeric form, with the ligand in a symmetrical hydrophobic tunnel...
February 28, 2024: Pharmaceuticals
https://read.qxmd.com/read/38539006/a-new-updated-prognostic-index-for-patients-with-brain-metastases-bms-treated-with-palliative-whole-brain-radiotherapy-wbrt-in-the-era-of-precision-oncology-metasncore-project
#32
JOURNAL ARTICLE
Pablo Flores-Paco, Alicia Vargas-Aliaga, María Geraldina Guevara, Ignacio Lopera, Lucía Rodríguez Ruiz, María López-Herrero, Juan Adrián Camús, Javier López-González, Elizabeth Inga-Saavedra, Marina Montero, Isidoro Barneto, Mª Auxiliadora Gómez-España, Estela Ruiz, Marta Ruza, Ana Armenta, Amalia Palacios, Juan R De La Haba-Rodríguez, Enrique Aranda
INTRODUCTION: Palliative WBRT is the main treatment for multiple BMs. Recent studies report no benefit in survival after WBRT compared to palliative supportive care in patients (pts) with poor prognosis. A new era of systemic treatment strategies based on targeted therapies are improving the prognosis of patients with BMs. The purpose of this study is to develop a prognostic score in palliative pts with BMs who undergo WBRT in this new setting. METHODS: 239 pts with BMs who received palliative WBRT between 2013-2022 in our center were analyzed retrospectively...
March 27, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38535825/comprehensive-analysis-of-bufadienolide-and-protein-profiles-of-gland-secretions-from-medicinal-bufo-species
#33
JOURNAL ARTICLE
Yunge Fang, Liangmian Chen, Pengfei Wang, Yating Liu, Yuxiu Wang, Zhimin Wang, Yue Ma, Huimin Gao
Toad Venom (TV) is the dried product of toxic secretions from Bufo bufo gargarizans Cantor (BgC) or B. melanostictus Schneider (BmS). Given the increasing medical demand and the severe depletion of wild toads, a number of counterfeit TVs appeared on the market, posing challenges to its quality control. In order to develop an efficient, feasible, and comprehensive approach to evaluate TV quality, a thorough analysis and comparison of chemical compounds among legal species BgC and BmS, as well as the main confusion species B...
March 20, 2024: Toxins
https://read.qxmd.com/read/38532893/bms-794833-reduces-anlotinib-resistance-in-osteosarcoma-by-targeting-the-vegfr-ras-cdk2-pathway
#34
JOURNAL ARTICLE
Qingtao Meng, Jian Han, Peng Wang, Chenxu Jia, Mingyang Guan, Bolun Zhang, Wenzhi Zhao
BACKGROUND: Osteosarcoma, a tumor that originates from bone cells, has a poor prognosis and a high degree of malignancy. Anlotinib, a small-molecule multi-target tyrosine kinase inhibitor (TKI), is the first-line drug in treating osteosarcoma, especially in late-stage osteosarcoma. However, patients often develop resistance after using anlotinib for a certain period, which poses a challenge to its further clinical application. Recently, several TKIs, for instance regorafenib and cabozantinib, have showed clinical interest in treating osteosarcoma and target both vascular endothelial growth factor receptor (VEGFR) and mesenchymal epithelial transition factor (c-MET)...
April 2024: Journal of Bone Oncology
https://read.qxmd.com/read/38528586/cortical-lipid-metabolic-pathway-alteration-of-early-alzheimer-s-disease-and-candidate-drugs-screen
#35
JOURNAL ARTICLE
Linshuang Wang, Fengxue Qu, Xueyun Yu, Sixia Yang, Binbin Zhao, Yaojing Chen, Pengbo Li, Zhanjun Zhang, Junying Zhang, Xuejie Han, Dongfeng Wei
BACKGROUND: Lipid metabolism changes occur in early Alzheimer's disease (AD) patients. Yet little is known about metabolic gene changes in early AD cortex. METHODS: The lipid metabolic genes selected from two datasets (GSE39420 and GSE118553) were analyzed with enrichment analysis. Protein-protein interaction network construction and correlation analyses were used to screen core genes. Literature analysis and molecular docking were applied to explore potential therapeutic drugs...
March 25, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38525374/extensive-stage-small-cell-lung-cancer-with-cystic-brain-metastases-a-report-of-two-cases
#36
Fei Cai, Di Wu, Junling Liu, Shuxi Song, Jingyu Li, Zhendong Zheng, Long Xu
OBJECTIVE: Cystic brain metastases (BMs) are rare in small cell lung cancer (SCLC), and there are limited data on the treatment and prognosis of cystic BMs. Whole brain radiotherapy has been the mainstay for BMs since several years. Immune checkpoint inhibitors in extensive stage small cell lung cancer (ES-SCLC) have been shown to be suitable for patients who experienced better overall survival and progress-free survival and have been approved as the first-line treatment for ES-SCLC. In this report, we described two ES-SCLC patients developed cystic BMs after immunotherapy, after which the patients continued to treat the primary lesion with immune checkpoint inhibitors and the cystic BMs with radiotherapy...
2024: Cancer Management and Research
https://read.qxmd.com/read/38521093/deciphering-the-shift-from-benign-to-active-relapsing-remitting-multiple-sclerosis-insights-into-t-regulatory-cell-dysfunction-and-apoptosis-regulation
#37
JOURNAL ARTICLE
Anat Achiron, Rina Falb, Shay Menascu, David Magalashvili, Mathilda Mandel, Polina Sonis, Michael Gurevich
BACKGROUND: Relapsing-remitting multiple sclerosis (RRMS), a common demyelinating disease among young adults, follows a benign course in 10-15% of cases, where patients experience minimal neurological disability for a decade following disease onset. However, there is potential for these benign cases to transition into a clinically active, relapsing state. OBJECTIVE: To elucidate the biological mechanisms underlying the transition from benign to active RRMS using gene expression analysis...
March 21, 2024: Neurobiology of Disease
https://read.qxmd.com/read/38515282/laparoscopic-sleeve-gastrectomy-combined-with-toupet-fundoplication-t-sleeve-a-short-report-of-a-japanese-obesity-patient-with-gastroesophageal-reflux-disease
#38
JOURNAL ARTICLE
Kohei Uno, Takahiro Masuda, Atsushi Watanabe, Kazuhide Sato, Naoko Fukushima, Yoshitaka Ishikawa, Keita Takahashi, Yoshihiro Shirai, Koichiro Haruki, Masami Yuda, Muneharu Fujisaki, Yuichiro Tanishima, Fumiaki Yano, Ken Eto
Laparoscopic sleeve gastrectomy (LSG) is the most frequently performed procedure in bariatric-metabolic surgery (BMS) worldwide, accounting for approximately 90% of BMS procedures in Japan. While numerous studies have reported on the safety and efficacy of LSG, gastroesophageal reflux disease (GERD) remains a major postoperative complication. Although Roux-en-Y gastric bypass (RYGB) is preferred for severe obesity with GERD, it is less suitable for Japanese patients who have a higher risk of gastric cancer due to the remnant stomach which is difficult to observe with esophago-gastro-duodenoscopy...
April 2024: Asian Journal of Endoscopic Surgery
https://read.qxmd.com/read/38515010/amitriptyline-effectiveness-in-burning-mouth-syndrome-an-in-depth-case-series-analysis
#39
JOURNAL ARTICLE
Douglas Rodrigues Gonçalves, Leonardo Monteiro Botelho, Vinícius Coelho Carrard, Marco Antônio Trevizani Martins, Fernanda Visioli
OBJECTIVES: To assess the effectiveness of amitriptyline (AMT), and to identify the determinants of the treatment's effectiveness in patients diagnosed with burning mouth syndrome (BMS). BACKGROUND: Treatment of BMS is challenging and no established treatment protocol is available. AMT may be an important treatment option, cout not all patients benefit from this drug. Studies assessing factors related to treatment response are valuable in improving decision-making...
March 21, 2024: Gerodontology
https://read.qxmd.com/read/38514081/-18-f-bms-986229-pet-to-assess-programmed-death-ligand-1-status-in-gastroesophageal-cancer
#40
JOURNAL ARTICLE
Samuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, Steven B Maron, Ping Gu, Geoffrey Y Ku, Joanne F Chou, Marinela Capanu, Ariel Antoine, Diane Loegel, Lara Feder, Steven Philemond, Serge K Lyashchenko, Jason S Lewis, Viktoriya Paroder, Amitabh Srivastava, Laura H Tang, Heiko Schoder, Yelena Y Janjigian
Anti-programmed death 1 (PD-1) inhibitors are the standard of care for advanced gastroesophageal cancer. Although recommendations and approval by regulatory agencies are often based on programmed death ligand 1 (PD-L1) expression, pathologic assessments of PD-L1 status have several limitations. Single-site biopsies do not adequately capture disease heterogeneity within individual tumor lesions or among several lesions within the same patient, the PD-L1 combined positive score is a dynamic biomarker subject to evolution throughout a patient's disease course, and repeated biopsies are invasive and not always feasible...
March 21, 2024: Journal of Nuclear Medicine
keyword
keyword
104376
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.